Rezolute, Inc. Common Stock (NV)
Symbol: RZLT (NASDAQ)
Company Description:
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
- Today's Open: $9.43
- Today's High: $9.725
- Today's Low: $9.175
- Today's Volume: 2.00M
- Yesterday Close: $9.4
- Yesterday High: $9.42
- Yesterday Low: $8.97
- Yesterday Volume: 2.44M
- Last Min Volume: 3
- Last Min High: $9.725
- Last Min Low: $9.725
- Last Min VWAP: $9.725
- Name: Rezolute, Inc. Common Stock (NV)
- Website: https://www.rezolutebio.com
- Listed Date: 2011-12-23
- Location: REDWOOD CITY, CA
- Market Status: Active
- CIK Number: 0001509261
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $853.63M
- Round Lot: 100
- Outstanding Shares: 90.81M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-22 | SCHEDULE 13G | View |
2025-09-17 | 10-K | View |
2025-09-17 | 8-K | View |
2025-09-02 | 8-K | View |
2025-08-27 | 4 | View |
2025-08-27 | 3 | View |
2025-08-20 | 8-K | View |
2025-08-08 | EFFECT | View |
2025-08-06 | SCHEDULE 13G/A | View |
2025-08-01 | CORRESP | View |
2025-07-24 | UPLOAD | View |
2025-07-18 | 8-K | View |
2025-07-17 | S-3 | View |
2025-06-26 | 4 | View |
2025-06-24 | 4 | View |
2025-06-23 | 4 | View |
2025-06-23 | 4 | View |
2025-06-13 | 4 | View |
2025-06-13 | 8-K/A | View |
2025-06-13 | 8-K | View |